Plasma microparticles and vascular disorders

Microparticles are circulating, phospholipid rich, submicron particles released from the membranes of endothelial cells, platelets, leucocytes and erythrocytes. Investigation into their biological activity has revealed diverse actions in coagulation, cell signalling and cellular interactions. These actions are mediated through their phospholipid rich surfaces and the expression of cell surface molecules which reflect their cell of origin and its state of activation.

[1]  F. Dignat-George,et al.  Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome , 2004, Thrombosis and Haemostasis.

[2]  E. Jaffe,et al.  Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. , 1997, Blood.

[3]  A. Baird,et al.  Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome , 2006, Journal of thrombosis and haemostasis : JTH.

[4]  H. Carp,et al.  Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. , 2004, Human reproduction.

[5]  N. Young,et al.  Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria , 2004, British journal of haematology.

[6]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[7]  Chantal M Boulanger,et al.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[8]  Tomohiro Sakamoto,et al.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.

[9]  L. Horstman,et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.

[10]  P. Baker,et al.  Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. , 2003, American journal of obstetrics and gynecology.

[11]  M. Mesri,et al.  Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[12]  K. Fukudome,et al.  Activated protein C induces the release of microparticle-associated endothelial protein C receptor. , 2005, Blood.

[13]  L. Horstman,et al.  Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation , 2005, Journal of thrombosis and haemostasis : JTH.

[14]  T. Shimazu,et al.  Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. , 2004, The Journal of trauma.

[15]  M. U. Nollert,et al.  Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. , 2000, Blood.

[16]  F. Dignat-George,et al.  Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. , 2002, Blood.

[17]  C. Hack,et al.  Microparticles from Patients with Multiple Organ Dysfunction Syndrome and Sepsis Support Coagulation through Multiple Mechanisms , 2001, Thrombosis and Haemostasis.

[18]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[19]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[20]  R. Hebbel,et al.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. , 2003, Blood.

[21]  E. Jaffe,et al.  Plasma From Patients With Idiopathic and Human Immunodeficiency Virus- Associated Thrombotic Thrombocytopenic Purpura Induces Apoptosis in Microvascular Endothelial Cells , 1996 .

[22]  S. Nomura,et al.  High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. , 2001, Atherosclerosis.

[23]  H. Kitayama,et al.  Significance of elevation in cell-derived microparticles after allogeneic stem cell transplantation: transient elevation of platelet-drived microparticles in TMA/TTP , 2005, Bone Marrow Transplantation.

[24]  Wolfgang Schramm,et al.  Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. , 2006, Blood.

[25]  C. Esmon,et al.  Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. , 1990, The Journal of biological chemistry.

[26]  B. Sibai,et al.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.

[27]  J. Freyssinet,et al.  Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. , 1999, Blood.

[28]  M. Goligorsky,et al.  Endothelium-derived microparticles impair endothelial function in vitro. , 2004, American journal of physiology. Heart and circulatory physiology.

[29]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.

[30]  V. Faure,et al.  Elevation of circulating endothelial microparticles in patients with chronic renal failure , 2006, Journal of thrombosis and haemostasis : JTH.

[31]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[32]  M. Mesri,et al.  Endothelial cell activation by leukocyte microparticles. , 1998, Journal of immunology.

[33]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[34]  L. Horstman,et al.  Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. , 2005, Journal of the American College of Cardiology.

[35]  S. Nomura,et al.  Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome , 2003, Thrombosis and Haemostasis.

[36]  T. Mori,et al.  The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. , 1994, The Biochemical journal.

[37]  L. Horstman,et al.  Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation , 2003, British journal of haematology.

[38]  G. FitzGerald,et al.  Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.

[39]  A. Matzdorff,et al.  Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. , 2002, Thrombosis research.

[40]  W. Jy,et al.  Elevated plasma endothelial microparticles in preeclampsia. , 2003, American journal of obstetrics and gynecology.

[41]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[42]  R. Nieuwland,et al.  Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.

[43]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[44]  H. Ogura,et al.  Development and Assessment of Enzyme Immunoassay for Platelet-derived Microparticles , 2001, Thrombosis and Haemostasis.

[45]  W. Jy,et al.  Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. , 2004, American journal of obstetrics and gynecology.

[46]  D. Desprez,et al.  Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction , 2003, Thrombosis and Haemostasis.

[47]  C. Esmon,et al.  Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function* , 2000, The Journal of Biological Chemistry.

[48]  宮崎 泰彦.  High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles , 1999 .

[49]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[50]  C. Sáez,et al.  Circulating platelet-derived microparticles in systemic lupus erythematosus , 2005, Thrombosis and Haemostasis.

[51]  P Lesavre,et al.  Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. , 2006, Kidney international.

[52]  C. Hack,et al.  Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.

[53]  A. Tedgui,et al.  Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction , 2001, Circulation.

[54]  P. Sims,et al.  Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. , 1991, Blood.

[55]  J. Nunemacher,et al.  Optimal management of giant cell arteritis and polymyalgia rheumatica , 2012, Therapeutics and clinical risk management.

[56]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[57]  A. Kastrati,et al.  Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction , 2004, Thrombosis and Haemostasis.

[58]  M. Matsumura,et al.  Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. , 2006, Diabetes research and clinical practice.

[59]  R. Adams,et al.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future , 2006, The Lancet Neurology.

[60]  A. Nagler,et al.  Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation , 2004, Bone Marrow Transplantation.

[61]  L. Horstman,et al.  Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. , 2002, International journal of cardiology.

[62]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[63]  L. Horstman,et al.  Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease , 2001, British journal of haematology.

[64]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.

[65]  R. Nieuwland,et al.  Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? , 2002, American journal of obstetrics and gynecology.